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Summary
Detection of Mycobacterium tuberculosis antigens by
professional phagocytes via toll-like receptors (TLR)
contributes to controlling chronic M. tuberculosis in-
fection. Lipomannans (LM), which are major lipogly-
cans of the mycobacterial envelope, were recently de-
scribed as agonists of TLR2 with potent activity on
proinflammatory cytokine regulation. LM correspond
to a heterogeneous population of acyl- and glyco-
forms. We report here the purification and the com-
plete structural characterization of four LM acyl-forms
from Mycobacterium bovis BCG using MALDI MS and
2D 1H-31P NMR analyses. All this biochemical work
provided the tools to investigate the implication of
LM acylation degree on its proinflammatory activity.
The latter was ascribed to the triacylated LM form, es-
sentially an agonist of TLR2, using TLR2/TLR1 hetero-
dimers for signaling. Altogether, these findings shed
more light on the molecular basis of LM recognition
by TLR.
Introduction
Mycobacterium tuberculosis is one of the most effective
human pathogens, with one-third of the world popula-
tion being infected. M. tuberculosis targets professional
phagocytes, including alveolar macrophages and den-
dritic cells, in which it survives and multiplies. The intra-
cellular location of M. tuberculosis shields it from anti-
bodies, so host protection is essentially mediated by
adaptive immunity response via mainly two subpopula-
tions of T cells, including Th1 and cytotoxic T cells [1]. An
efficient T cell immune response against M. tuberculosis
is critically dependent on the rapid detection of the in-
vader by the innate immune system. Toll-like receptors
(TLR) contribute to innate immunity by the recognition
of mycobacteria-associated molecular patterns and by
mediating the secretion by professional phagocytes of
proinflammatory cytokines, such as TNF-a, IL-12, and
chemokines.
*Correspondence: martine.gilleron@ipbs.frMacrophages express a large diversity of TLR. Viable
or dead M. tuberculosis activate murine macrophages
via TLR2 and, to a lesser extent, via TLR4 [2]; however,
all the mycobacterial TLR ligands identified so far (i.e.,
the 19 kDa lipoprotein [3], PIM2 [4], PIM6 [5], and LM
[6, 7]) are TLR2 agonists. Recently, it has been proposed
that M. tuberculosis ligation, via mannosylated lipoara-
binomannans (ManLAM), to the C-type lectin receptors
(CLR) present at the surface of macrophages and den-
dritic cells might allow M. tuberculosis to escape im-
mune surveillance [8–10]. Indeed, ManLAM ligation to
the CLR, mannose receptor, or DC-SIGN alters the
proinflammatory response induced by the TLR4 agonist
LPS [8–10]. This inhibitory activity has been tentatively
attributed to an increase in IL-10 secretion [10]. ManLAM
is a 17 kDa macromolecule of the M. tuberculosis
envelope exhibiting a tripartite structure composed of
a mannosyl-phosphatidyl-myo-inositol anchor (MPI),
a polysaccharidic core, and mannose caps. We have
shown that ManLAM inhibitory activity requires both
the presence of at least two fatty acyl substituents on
the MPI anchor and the mannose caps [9]. In contrast
to ManLAM, PIM2, PIM6, and LM, the structure of which
is based on the same MPI anchor as that of ManLAM, are
TLR2-dependent proinflammatory molecules [5, 7]. They
are built from an MPI anchor bearing two or six Manp
units or a much larger D-mannan homopolysaccharide
extension, respectively.
NMR studies conducted on PIM2 [11, 12], PIM6 [5], LM
[11], and LAM [13, 14] led us to discover the existence of
different ‘‘acyl-forms.’’ They correspond to molecules
differing by the number and the position of the fatty
acid residues on the MPI anchor. The NMR strategies
developed for PIM studies allowed the characterization
of the potential acylation sites, corresponding to both
positions of the Gro, position 3 of the myo-Ins and posi-
tion 6 of the Manp unit linked at C-2 of the myo-Ins. In
this way, mono- to tetra-acylated forms of PIM2 and
PIM6 have been described [5, 11, 12]. As previously
mentioned, the acylation positions were determined
thanks to 2D NMR studies, while the structure of fatty
acids on each position was assessed by mass spec-
trometry (ESI or MALDI). The LM structural feature ap-
peared more difficult to investigate due to both its higher
molecular weight and heterogeneity, thus preventing
a complete NMR analysis.
The present study was devised to determine the influ-
ence of LM acylation pattern on its TLR-mediated proin-
flammatory activity. The different LM acyl-forms were
fractionated and structurally characterized using 2D
NMR spectroscopy and MALDI-TOF MS. We provide
evidence that the various acyl-forms have different
abilities to trigger TLRs to induce the production of
proinflammatory cytokines from murine and human
macrophages. Indeed, in contrast to PIM that are proin-
flammatory irrespective of their acylation degree, tri-
and tetra-acylated forms of LM (Ac3LM and Ac4LM, re-
spectively) were active, but not mono- and diacylated
LM (Ac1LM and Ac2LM, respectively). Thus, this study
suggests a subtle molecular mechanism involving the
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40Figure 1. Purification of the M. bovis BCG LM Acyl-Forms Mixture and Negative MALDI Mass Spectra of the Purified Fractions A–D
(A) Hydrophobic interaction chromatography on octyl-sepharose of the M. bovis BCG LM acyl-forms mixture. The column was eluted with
a propanol-1 linear gradient (20%–40%, v/v) in 0.1 M ammonium acetate in water. Fractions were analyzed by HPAEC for their mannose content.
(B) Negative MALDI mass spectra of the fraction A, which corresponded to mono-acylated forms, acylated by 1C16 or 1C19.
(C) Negative MALDI mass spectra of the fraction B, which corresponded to diacylated forms, acylated by 2C16 or 1C16/1C19.
(D) Negative MALDI mass spectra of the fraction C, which corresponded to triacylated forms, acylated by 2C16/1C19 or 1C16/1C18/1C19.
(E and F) Negative MALDI mass spectra of the fraction D, which corresponded to tetra-acylated forms, acylated by 3C16/1C19, 2C16/2C19 or, in
small part, by 2C16/1C18/1C19. Fatty acyl compositions were based on the most abundant fatty acyl chains found by GC MS analysis (i.e., palmitate
[C16], tuberculostearate [C19] and, to a lesser extent, stearate [C18]).MPI anchor acylation degree of LM by whichM. tubercu-
losis might influence macrophage activation.
Results
Characterization of LM Acyl-Forms by NMR
LM were isolated from Mycobacterium bovis BCG and
purified as previously described [11]. 1D 31P NMR high-
lighted the presence of different LM acyl-forms. Indeed,
the spectrum of LM solubilized in Me2SO-d6 showed five
sharp phosphorus resonances at d 1.73 (P1), d 1.78 (P2),
d 1.90 (P3), d 3.40 (P4) and d 3.57 (P5), with relative inte-
gration values of 1.0 for P1 and P2, 0.9 for P3, 0.1 for P4,
and 0.3 for P5, typifying at least five acyl-forms (as pre-
viously described in [11]). Using 2D 1H-31P HMQC-
HOHAHA experiments, three of the four acylation sites
of the MPI anchor were characterized, on both positions
of the Gro, and on C3 of the myo-Ins [11]. P1, P2, and P3
acyl-forms were shown to contain diacyl Gro, while
those of P4 and P5 contained mono-acyl Gro. In the
case of P1 and P4 acyl-forms, an additional fatty acyl
residue was found located at the C3 of the myo-Ins.
LM thus appeared as a mixture of at least mono-, di-,
and triacylated acyl-forms, with a putative additional
fatty acyl appendage on the C6 of the Manp residue of
the MPI anchor [11]. Integration of the phosphorus sig-
nals indicated that the most abundant acyl-forms were
those that were at least triacylated (P1) and diacylated
(P3) (32% and 38%, respectively). LM fatty acids com-
position was previously determined by GC as a combi-nation of palmitic (C16, 62%), tuberculostearic (10-meth-
yloctadecanoic) (C19, 30%), and stearic (C18, 8%) acids
[11]. Therefore, NMR studies identified four acyl-forms
that were further investigated using MALDI-TOF MS.
We intended to determine whether these LM acyl-forms
contained an additional fatty acyl residue, and how the
acyl substituents were distributed on each acyl-form.
To overcome the problems of species discrimination
or ionization efficiency occurring during LM mixture
analysis (unpublished data), we decided to purify the dif-
ferent LM acyl-forms prior to MALDI-TOF MS analysis.
Fractionation and Structural Characterization
of LM Acyl-Forms
LM acyl-forms mixture was fractionated using hydro-
phobic interaction chromatography. The elution profile
(Figure 1A) showed four peaks, two of weak intensity
(A and D), eluting at approximately 24% and 40% prop-
anol-1 in 0.1 M ammonium acetate in water, respec-
tively, and two of higher intensity (B and C), eluting at ap-
proximately 30% and 35% propanol-1, respectively. The
fractions corresponding to the different peaks were
pooled (fractions A–D), dialyzed, and dried. The relative
mass abundance of the different fractions was 7% for A,
29% for B, 56% for C, and 8% for D. Each fraction was
analyzed by negative MALDI-TOF MS (Figures 1B–1E)
using DHB solubilized in 1/1 (v/v) ethanol/water, and
by 1D 31P (Figure 2) and 2D 1H-31P NMR in Me2SO-d6
to localize the fatty acyl substituents on the MPI anchor
of the different purified acyl-forms.
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1B) was dominated by one set of peaks assigned to mo-
nopalmitoylated LM with a mannan domain composed
of up to 48 Manp units. The presence of another set of
peaks with a much lower intensity was also observed
and characterized as monotuberculostearoylated LM.
The 1D 31P spectrum of this fraction (Figure 2B) ex-
hibited a single resonance at 3.50 ppm, characterizing
an MPI anchor with a lyso-Gro, as previously described
[11]. In summary, fraction A contained mono-acylated
LM, mainly esterified by palmitoyl on the Gro unit.
Figure 1C shows the mass spectrum of fraction B,
highlighting two distinct sets of diacylated LM. The
most abundant LM acyl-form was assigned to LM con-
taining one palmitoyl and one tuberculostearoyl ap-
pendage, while the other one corresponded to dipalmi-
toylated LM. As in the case of the Ac1LM, the mannan
domain was composed of 15–48 Manp units. The 1D
31P spectrum of fraction B (Figure 2C) showed two res-
onances, revealing that Ac2LM is composed of two iso-
forms differing by the positions of the fatty acids. The
first resonance at 3.84 ppm (P5) revealed a lyso-Gro,
while the other at 1.97 ppm (P2) typified a diacyl Gro.
The 2D 1H-31P experiments (data not shown) indicated
that the myo-Ins unit was not acylated. We thus de-
duced that in the case of the acyl-form with a lyso-
Gro, the second acylation site was on the Manp unit of
the MPI, assigning the acyl-form characterized by P5.
Figure 1D shows the mass spectrum of fraction C. It is
dominated by one set of peaks assigned to triacylated
LM containing two palmitoyl and one tuberculostearoyl
substituents. The mannan domain is again composed
of 15–48 Manp units. The 1D 31P spectrum of the triac-
ylated LM (Figure 2D) exhibited a single resonance at
d 1.81 ppm, corresponding to an MPI anchor with
a diacyl Gro. By 1H-31P 2D NMR experiments (data not
shown), we found that this phosphorus resonance cor-
responded to P3 (Figure 2A), the myo-Ins being non-ac-
ylated. We concluded that the third position of acylation
was the C6 of the Manp unit of the MPI. A less abundant
population was revealed by a weaker 31P resonance at
d 3.45, attributed to an MPI anchor with a lyso-Gro. As
this fraction corresponds to triacylated LM, both re-
maining acylation sites are thus substituted. This 31P
resonance is then likely to correspond to P4.
Finally, fraction D contained tetra-acylated LM (Figure
1E) composed of three or two palmitoyl combined to one
or two tuberculostearoyl appendages, respectively (Fig-
ure 1F). Species containing two palmitoyl combined to
one stearoyl and one tuberculostearoyl substituents
were found in minor abundance (Figure 1F). The mannan
domain was composed of 18–41 Manp units (Figure 1E).
The 1D 31P spectrum of the tetra-acylated LM (Figure 2E)
showed a single resonance at d 2.01 ppm, indicating the
presence of a diacyl Gro. The resonance was assigned
to P1 (Figure 2A). The presence of four fatty acyl groups
implied that all the MPI acylation positions were acyl-
ated: both positions of Gro, C6 of the Manp unit, and
C3 of myo-Ins unit. It is of note that 31P chemical shifts
of the purified acyl-form of LM (Figure 2E) were different
from those observed within the mixture (Figure 2A) as
a result of different environments. Therefore, the 31P
chemical shift value alone cannot be used to determine
acylation degree of a molecular species, but is neverthe-less informative on the degree of substitution of Gro
(lyso- or diacylated).
In summary, four major LM acyl-forms were charac-
terized, differing by their degree of acylation, the most
abundant being the diacylated and the triacylated
forms. Each acyl-form, defined by the total number of
fatty acids, is still heterogeneous according to its acyla-
tion pattern. Indeed, they are composed of subpopula-
tions defined by two additional criteria: the type and
the position of fatty acids substituents. As such,
Ac1LM consist of two subpopulations, acylated by either
C16 or C19 fatty acyl residues on the Gro (Figure 3).
Ac2LM are composed of two molecular subspecies,
comprising 1C16 and 1C19 or 2C16, and two isoforms
Figure 2. 1D 31P Spectra of the LM Mixture and the Purified LM
Acyl-Forms
Expanded regions of the 1D 31P spectra of the LM mixture (A) and
the purified LM acyl-forms (B–E) dissolved in Me2SO-d6 at 343 K
(d 31P: 0.00–5.00): mono- (B), di- (C), tri- (D), and tetra- (E) acylated
forms of LM (corresponding to the fractions A–D eluted from the
hydrophobic interaction chromatography, respectively).
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form contains lyso-Gro and acyl-Manp units (Figure 3),
while the other is characterized by a diacylated Gro.
Ac3LM are dominated by a molecular species esterified
by 2C16 and 1C19, distributed on the Gro and on the
Manp, similarly to Ac4LM that bear a fourth fatty acyl
substituent, C16 or C19, on the myo-Ins. All the acyl-
forms showed a major glyco-form containing 26 Manp
units. The mass values of the deprotonated molecular
ions characterized LM containing around 15–45 Manp
units.
Human and Murine Macrophages Stimulation
by Purified M. bovis BCG LM Acyl-Forms
We have recently shown that M. bovis BCG LM total
fraction stimulates murine primary macrophage activa-
tion and effector functions, such as the release of
TNF-a and IL-12 [7]. Here, we tested the different puri-
fied M. bovis BCG LM acyl-forms for their capacity to
induce the secretion of proinflammatory cytokines
TNF-a and IL-12 by murine macrophages (Figure 4). As
previously reported, LM mixture (3 mg/ml) induced ele-
vated production of TNF-a (Figures 4A and 4B) and
IL-12p40 (data not shown) by murine macrophages,
reaching a plateau at a level obtained with classical
macrophage activators, such as LPS (100 ng/ml) or the
bacterial lipopeptide Pam3CSK4 (BLP) (0.5 mg/ml).
Purified Ac4LM and Ac3LM induced elevated produc-
tion of TNF-a (Figures 4A and 4B) and IL-12p40 (data not
Figure 3. Proposed Structural Model of M. bovis BCG LM
This model is based on both MALDI and NMR data. MALDI-TOF MS
experiments revealed glyco-forms containing 15–45 mannosyl
units, with a systematic preponderance of the glyco-form with 26
Manp units, leading to 15 < 2m + n < 45. Integration of the anomeric
signals on the 1H NMR spectrum provided an average value for the
substitution degree of the 6-O-linked mannan backbone, leading to
an n value of 2 or 3 [11]. The proposed model for the mannan core
does not account for the relative distribution of the mannobiose or
mannosyl units along the backbone. The nature of the terminal res-
idue remains to be elucidated. Fatty acids composition (C16 and
C19) is in agreement with GC data; the structure and the position
of the fatty acyl appendages on the Gro were previously deter-
mined after acetolysis followed by GC/MS analysis [11].shown). In contrast, Ac1LM induced a much lower re-
sponse, and Ac2LM were essentially inactive, even at
high concentration (Figure 4B). Therefore, of the four
LM acyl-forms, Ac3LM and Ac4LM are the predominant
inducers of the proinflammatory cytokines TNF and
IL-12p40.
We next investigated whether the proinflammatory
activity of the Ac3LM and Ac4LM was also observed on
human monocytic cells, using the THP-1 cell line (Figure
4C). Likewise, we found that Ac3LM and Ac4LM induced
elevated production of TNF-a, whereas Ac1LM and
Ac2LM were essentially inactive, even at high concentra-
tions (10 and 20 mg/ml) (Figure 4C). Therefore, LM proin-
flammatory activity on human monocytic cells was also
dependent on the acylation degree and associated with
tri- and tetra-acylated forms.
Figure 4. TNF-a Production by Primary Murine Macrophages and
by Human Monocytic THP-1 Cell Line in Response to LM Acyl-
Forms Mixture or Purified LM Acyl-Forms
TNF-a production by primary murine macrophages (A and B) and
by human monocytic THP-1 cell line (C) in response to LM acyl-
forms mixture or purified LM acyl-forms. (A and B). Murine bone
marrow-derived macrophages were incubated with LPS (100 ng/
ml), Pam3CSK4 (BLP; 0.5 mg/ml), BCG LM acyl-forms mixture, or
purified LM acyl-forms at 3 mg/ml (A and C) or LM titrations from
1 to 10 mg/ml (B). After 24 hr of incubation, TNF-a (A and B) levels
were measured in the supernatants. Results are mean 6 SD from
n = 2 mice, and are from one representative experiment of four in-
dependent experiments. (C) LM mixture or purified LM acyl-forms
were tested at 10 (black bars) and 20 (white bars) mg/ml.
LM Glyco- and Acyl-Forms and Proinflammatory Response
43TLR2- and TLR4-Dependence Study of Macrophage
Stimulation by the Major LM Acyl-Form, Ac3LM
The TLR dependence of M. bovis BCG LM TNF-a-induc-
ing activity was then investigated using specific anti-
TLR2 and anti-TLR4 neutralizing antibodies on human
THP-1 cells. The anti-TLR2 antibody significantly in-
hibited TNF-a production induced by LM, whereas the
anti-TLR4 antibodies had no effect, as compared with
an IgG2 isotype control (data not shown). These results
document the role of TLR2 in mediating the stimulation
of TNF-a production by human monocytic cells in re-
sponse to M. bovis BCG LM. The results are in agree-
ment with our results in macrophages from TLR2-defi-
cient mice, where TNF-a release in response to M.
bovis BCG LM was sharply decreased as compared
with wild-type macrophages [7].
Furthermore, we analyzed the TLR-dependence of
the major LM acyl-form-induced proinflammatory re-
sponses. Macrophages from mice deficient in TLR2,
TLR4, or both were stimulated with the purified Ac3LM
acyl-forms (Figure 5A). TLR4 agonist LPS and TLR2 ag-
onist BLP were used as controls of TLR2/4 specificity.
Ac3LM induced an elevated TNF-a release in the super-
natant of wild-type macrophages, but this response was
reduced by up to 95% in macrophages deficient in TLR2
in five independent experiments, whereas absence
of TLR4 caused a sharp reduction in TNF-a, and no
TNF-a could be detected in the supernatant of macro-
phages deficient in TLR2 and TLR4. Thus, Ac3LM show
a strong TLR2 agonist activity, as well as some TLR4 ag-
onist activity. To evaluate a putative contribution of con-
taminating endotoxins to the TLR4-mediated activity of
LM acyl-forms, endotoxin levels were quantified in the
different LM acyl-forms by kinetic turbidimetric assays
(see Experimental Procedures). LPS was downtitrated
and tested side-by-side with Ac3LM to evaluate the
contribution of endotoxins in the induction of TNF-a. It
appeared that some of the TLR4 agonist activity of
Ac3LM could be due to the level of endotoxin present
in the preparation (18.9 ng per 10 ug of Ac3LM).
Altogether, these results suggest that the fraction
containing Ac3LM induces TNF-a secretion through
a TLR2-dependent pathway. No cytokine production
was detected in the supernatants of macrophages iso-
lated from the double TLR2- and TLR4-deficient mice,
indicating that TLR2 and TLR4 represent the main re-
ceptors for the different M. bovis BCG LM acyl-forms.
TLR2 Heterodimerization for the Cytokine
Stimulation by Ac3LM
TLR2 is known to form heterodimers with TLR1 or TLR6
[15–17]. We have previously shown that the TLR2-de-
pendent stimulatory activity of M. bovis BCG LM total
fraction was independent of TLR6 [7]. Here we assessed
whether TLR1 is involved in the immune response to
Ac3LM. Macrophages deficient in TLR1 or TLR2 showed
a markedly reduced TNF-a production in response to
stimulation with Ac3LM, whereas, as expected, there
was no decrease in the response of macrophages defi-
cient in TLR6 (Figure 5B). Although less pronounced,
the same trend was observed with the M. bovis BCG
LM total fraction. Absence of either TLR1 or TLR6 had
essentially no effect on the response to the TLR4 agonist
LPS, or to the TLR9 agonist CpG. The TLR2 agonist BLPshowed a reduced response in TLR1-deficient macro-
phages, although this was not as pronounced as in
TLR2-deficient cells. Similar data were obtained for IL-
12p40 secretion, suggesting that TLR1 is involved in
the TLR2-dependent activation by Ac3LM (data not
shown).
Thus, the release of proinflammatory cytokines by pri-
mary murine macrophages stimulated with Ac3LM seems
to be mediated through both TLR2 and TLR1, which may
function as heterodimers, and not through TLR6.
Discussion
M. tuberculosis targets macrophages and dendritic cells
in which it survives and multiplies. An efficient immune
response against M. tuberculosis is critically dependent
on its rapid detection through conserved molecular pat-
terns by the innate immune system receptors, including
TLR, that mediate the production of proinflammatory cy-
tokines. Recently, a strategy has been evidenced by
which M. tuberculosis might be able to escape immune
surveillance. Indeed, binding ofM. tuberculosis to the C-
Figure 5. TLR-Dependence of the TNF-a Release Induced by LM
Acyl-Forms
(A) TLR2- and TLR4-dependence of the TNF-a release induced by
LM acyl-forms. Bone marrow-derived macrophages from mice de-
ficient for TLR2, TLR4, or TLR2 and TLR4 were incubated with me-
dium alone, with BCG LM, or the different LM acyl-forms at a con-
centration of 3 mg/ml, or with LPS (100 ng/ml) or Pam3CSK4 (BLP;
0.5 mg/ml) as TLR4 and TLR2 reference agonist, respectively. TNF
was measured after 24 hr in the supernatants.
(B) TLR2/1-dependence of the TNF-a release induced by M. bovis
BCG Ac3LM. Bone marrow-derived macrophages from mice defi-
cient in TLR1, TLR2, or TLR6 were incubated with medium alone,
total LM from M. bovis BCG (BCG LM) or M. bovis BCG triacylated
LM (BCG Ac3LM) at a concentration of 3mg/ml, or with LPS (100 ng/
ml) or CpG (0.125mM) for 24 hr. TNF was measured in the superna-
tants by ELISA.
Results are mean 6 SD from n = 2 mice per genotype, and are rep-
resentative of three independent experiments.
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brane of phagocytes, has been shown to alter TLR-me-
diated signaling [9, 10]. M. tuberculosis is recognized by
TLR2 and, to a lesser extent, by TLR4 [2, 4, 18–20]. Puri-
fied mycobacterial LM have been shown in vitro to acti-
vate macrophages in a TLR2-dependent manner, lead-
ing to the production of proinflammatory cytokines [6,
7, 21]. Recent studies have revealed how soluble LM
could function as TLR2 ligands in the context of a myco-
bacterial infection. Indeed, it is now clear that mycobac-
terial compounds, including LM, can be delivered from
infected macrophages to noninfected bystander den-
dritic cells equipped with TLR receptors [22–25]. The re-
lease of LM from infected macrophages is mediated by
at least two described mechanisms. On the one hand,
lipid-containing moieties of the mycobacterial cell wall
have been shown to be actively trafficked out of the my-
cobacterial vacuole, transported to endosomes/lyso-
somes, and ultimately found in extracellular vesicles iso-
lated from the culture medium. On the other hand, it has
been recently demonstrated that mycobacteria induce
apoptosis of the macrophages that they infect, causing
the release of apoptotic vesicles carrying TLR2 ligands,
including LM.
In order to improve our insights into the structure/
function relationships underlying the TLR-mediated
proinflammatory activity of LM, we assessed the role
of the degree of acylation of the molecule. A prerequisite
of this work was the fractionation of LM acyl-forms and
their chemical characterization using 2D NMR and
MALDI MS.
The LM acyl-forms were first revealed by 1D 31P NMR
studies, and their structure was investigated in the total
mixture using 2D 1H-31P NMR [11]. Using NMR, three
sites of acylation were characterized, including two on
the Gro and one at the myo-Ins at position C3. By anal-
ogy to PIM, an additional acylation site at the C6 of the
Manp was postulated. This structural uncertainty was
removed in the present study using negative MALDI-
TOF MS. Indeed, MALDI-TOF MS appeared as an appro-
priate analytic tool to reveal and determine the molecu-
lar weight of the LM acyl-forms and, consequently, to
define the number and nature of fatty acid residues
and the number of Manp units present on the molecule.
The LM acyl-forms mixture was fractionated using hy-
drophobic interaction chromatography [9, 26] and sepa-
rated into four subfractions, namely A–D, from the most
hydrophilic to the most hydrophobic LM. These frac-
tions were characterized by MALDI-TOF MS and 2D
1H-31P NMR.
In summary, four major LM acyl-forms were charac-
terized, differing in their degree of acylation, the most
abundant ones being the diacylated and the triacylated
forms. Fraction A contained Ac1LM acylated on the C1
of Gro by C16 and, to a lesser extent, by C19. Fraction
B contained two isoforms of Ac2LM, the major one con-
taining a lyso-Gro and an acyl-Manp unit, the minor one
containing a diacylated Gro residue. The fatty acids
composition was 1C16/1C19 or, to a lesser extent, 2C16.
Fraction C corresponded to Ac3LM, mainly composed
of one isoform, with the Gro and the Manp being acyl-
ated almost exclusively by 2C16/1C19. Finally, fraction
D contained Ac4LM esterified by 3C16/1C19, 2C16/2C19,
and, to a lesser extent, 2C16/1C18/1C19. Whatever the ac-ylation degree, the number of Manp units for each acyl-
form varied between 15 and 45, with a systematic pre-
ponderance of the glyco-form containing 26 Manp units.
Tetra-acylated forms have been clearly demonstrated
for PIM2 [11, 12] and PIM6 [5], but the corresponding
acyl-forms of LM or LAM have only been suspected
thus far [9, 11, 13, 27]. The present study reveals the ex-
istence of tetra-acylated LM. Interestingly, the abun-
dance and fatty acid composition of mono-, di-, tri-,
and tetra-acylated acyl-forms are similar for PIM2,
PIM6, and LM, except that the relative abundance of
the diacylated isoforms is different between PIM2 and
LM (see Table S1 in the Supplemental Data), supporting
the concept of a biosynthetic linkage between PIM and
LM, as previously hypothesized [12, 27]. Moreover, the
heterogeneity of LM is here characterized in terms of
glyco-forms. The exact number of mannose units pres-
ent on each LM acyl-form was thus determined. To
date, only an average number of Manp units per mole-
cule was tentatively obtained by integrating the man-
nose and inositol signals on the gas chromatograms af-
ter total acid hydrolysis of LM mixture [28, 29]. In
contrast, the MALDI-TOF mass spectra reveal the pres-
ence of the different glyco-forms that can contain up to
50 Manp units and, as such, highlight LM molecular
complexity in terms of mass distribution and degree of
mannosylation. MALDI-TOF results are in agreement
with the previously published data [21], as they indicate
a similar average number of Manp units per molecule,
the glyco-forms with a very high number of Manp being
present in small amounts. However, the present results
reveal a large molecular distribution that was not sus-
pected from previous analyses.
Having isolated and chemically characterizedM.bovis
BCG LM acyl-forms, we next determined their capacity
to induce the proinflammatory cytokines TNF-a and IL-
12, as well as their TLR usage. Ac1LM showed a poor ac-
tivity and Ac2LM failed to induce cytokine production,
whereas Ac3LM and Ac4LM strongly activated human
monocytic cells and primary murine macrophages to re-
lease TNF-a and IL-12p40. As expected, TLR2 and TLR4
seemed to be the major TLR triggered by the LM acyl-
forms, as no stimulation was obtained in the absence
of both receptors. Ac3LM, the most abundant acyl-
form with Ac2LM, induced a strong stimulatory signal,
mostly mediated through TLR2, as observed for the orig-
inal mixture of M. bovis BCG LM acyl-forms. Thus, LM
proinflammatory activity requires at least three fatty
acids on the molecule. However, the size of the mannan
domain also modulates this activity. Indeed, PIM2 and
PIM6 that have a shorter mannan domain, composed
of two and six Manp units, respectively, also signal via
TLR2, but their activity is dramatically reduced as com-
pared with that of LM (at least 10-fold less) [5, 6].
Our data raised the question of the role of fatty acids
for LM signaling via TLR2: why do Ac3- and Ac4LM
show a proinflammatory activity, while Ac1- and Ac2LM
do not? TLR2 are known to mediate the recognition of
a variety of microbial components, such as bacterial lip-
opeptides and lipoproteins, porins, peptidoglycan, GPI-
anchors, and lipotechoic acids [30]. Some of the ligands
are recognized by heterodimers formed between TLR2
on the one hand, and TLR1 or TLR6 on the other. Inter-
estingly, murine TLR2 discriminates between di- and
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45triacylated lipopeptides, in cooperation with TLR6 or
TLR1, respectively [30]. Among these lipopeptides is
the 2 kDa macrophage-activating lipopeptide, MALP-2,
from mycoplasmas. Synthetic variants of MALP-2, shar-
ing an identical peptide moiety but substituted with
different lipid moieties, have helped to define the TLR
system of recognition by using mouse fibroblasts bear-
ing genetic deletions of various TLRs [31]. It has been
shown that the removal of one or both ester-bound fatty
acids lowered or deleted biological activity, indicating
that esterification of the 3-deoxy-3-thio-Gro residue by
two fatty acids is required to optimally stimulate innate
immunity via TLR2 [3]. Ac1LM and the major isoform of
Ac2LM, which are not active, carry a single acyl residue
on the Gro. Thus, as for MALP-2, it seems that optimal
TLR2 activation by LM requires two fatty acids on the
Gro moiety, a structural feature observed in Ac3LM.
Moreover, as reported for triacylated lipopeptides [3],
Ac3LM signaling via TLR2 required dimerization of
TLR2 with TLR1.
In conclusion, this study helps to refine our under-
standing of the molecular basis of TLR2-mediated LM
proinflammatory activity, and defines Ac3LM as an addi-
tional mycobacterial ligand of TLR2 aside from the 19
kDa lipoprotein, PIM2, and PIM6. The host defense
against pathogenic microorganisms such as M. tuber-
culosis comprises innate and adaptive immunity. Stud-
ies in mice have shown that TLR2 contributes to the bat-
tle against M. tuberculosis infection. Indeed, TLR22/2
mice are more susceptible to infection with high doses
of M. tuberculosis [20, 32, 33], while resistance to M. tu-
berculosis infection is marginally affected in TLR42/2
mice [19]. Moreover, absence of both TLR2 and TLR4
does not compromise resistance to M. bovis BCG infec-
tion [34]. In humans, a higher expression of TLR2 and
TLR1 has been found in skin lesions from patients with
the localized tuberculoid form of leprosy as compared
with those with disseminated lepromatous disease [4].
An arginine-tryptophane mutation was also found in
the cytoplasmic domain of TLR2 of a subset of leproma-
tous leprosy patients from Korea, and cells transfected
with this mutated TLR2 were not able to mediate activa-
tion of NF-kB after stimulation with Mycobacterium
leprae [35].
Altogether, these observations should prompt the
testing of mycobacterial TLR2 ligands, such as PIM
and Ac3LM, as adjuvants together with immunogenic
proteins for the development of an efficient subunit vac-
cine to prevent M. tuberculosis infection [36].
Significance
Toll-like receptors (TLR) are receptors of the innate
immune system designed to rapidly detect invasion
of microbial pathogens such as Mycobacterium tuber-
culosis. They control innate immunity response and
subsequent activation of adaptive immunity. Lipo-
mannans (LM) are major lipoglycans of the myco-
bacterial envelope and activate macrophages in a
TLR2-dependent manner, leading to the production
of proinflammatory cytokines. However, they are het-
erogeneous molecules composed of different acyl-
forms and glyco-forms. To get better insights into the
structure/function relationships, we investigated therole of LM acylation state in their ability to activate mac-
rophage via TLR2. Four acyl-forms of LM (mono- to
tetra-acylated: Ac1- to Ac4LM) were purified and struc-
turally characterized. The heterogeneity of LM in terms
of glyco-forms was also determined. The proinflamma-
tory activity of LM was ascribed to the triacylated form
essentially. Optimal TLR2 activation by LM seems to
require two fatty acyl substituents on the glycerol
unit, a structural feature observed in Ac3LM, but not
in Ac1- or Ac2LM.
Experimental Procedures
Mycobacterial LM Purification
LM fromM. bovisBCG Pasteur strain were purified as previously de-
scribed [11]. Briefly, the delipidated mycobacteria were extracted by
refluxing in 50% ethanol. The resulting cells were then washed and
disintegrated by sonication and by use of a French pressure cell,
and extracted by refluxing in 50% ethanol. This latter extract, con-
taining LAM, LM, and AM, was used and cleared from proteins
and glucans by enzymatic digestion and hot aqueous phenol bi-
phasic wash. Triton X-114 phase separation was used to sepa-
rate glycans (AM) from amphipatic conjugates (LM and LAM) [37].
ManLAMs and LM were then separated by gel filtration. The purified
LM, monitored by SDS-PAGE, as described by Venisse et al. [38],
were observed as a broad band located around 20 kDa, indicating
that LM were not contaminated by LAM.
MALDI-TOF MS
Analysis by MALDI-TOF MS was carried out on a Voyager DE-STR
(PerSeptive Biosystems, Framingham, MA) using the linear or reflec-
tron modes. Ionization was effected by irradiation with pulsed UV
light (337 nm) from an N2 laser. LM were analyzed by the instrument
operating at 24,500 V in the negative ion mode using an extraction
delay time set at 200 ns. Spectra from 250 to 500 laser shots were
summed to obtain the final spectrum. The DHB matrix (Sigma Chem-
ical, St. Louis, MO) was used at a concentration ofw10 mg/ml in wa-
ter or ethanol/water (1/1, v/v), as indicated. Typically, 0.5 ml of LM
sample (5–10 mg) in water and 0.5 ml of the matrix solution, were de-
posited on the target, mixed with a micropipette, and dried under
a gentle stream of warm air. The laser intensity was set to 2500/2700.
Hydrophobic Interaction Chromatography of LM
A quantity of 26 mg of LM was loaded in 0.1 M ammonium acetate
solution containing 20% (v/v) propanol-1 to an octyl-Sepharose
CL-4B column (20 3 1.5 cm; Pharmacia, Orsay, France) preequili-
brated with the same buffer. The column was first eluted with 25
ml of equilibration buffer and then with a linear propanol-1 gradient
from 20% to 40% (v/v) (100 ml each) in 0.1 M ammonium acetate so-
lution at a flow rate of 5 ml/hr. Each fraction was collected over 30
min. The column was finally eluted with 200 ml of 0.1 M ammonium
acetate solution containing 40% (v/v) propanol-1.
A 20 ml sample of each fraction was dried and subjected to acidic
hydrolysis (100 ml 2M trifluoroacetic acid for 2 hr at 110ºC). The hy-
drolysates were dried, reconstituted in water, and then analyzed
by high-pH anion exchange chromatography (HPAEC) for mannose
content determination.
According to the mannose contents profile, the fractions were
pooled and precipitated with ethanol. A total of 0.7 mg of Ac1LM,
2.8 mg of Ac2LM, 5.4 mg of Ac3LM, and 0.8 mg of Ac4LM were
retrieved.
NMR Analysis
NMR spectra were recorded with an Avance DMX500 spectrometer
(Bruker GmbH, Karlsruhe, Germany) equipped with an Origin 200
SGI using Xwinnmr 2.6. Samples were exchanged in 2H2O with inter-
mediate freeze-drying, then dissolved in Me2SO-d6, and analyzed at
343 K. The 1D phosphorus (31P) spectra were measured at 202.46
MHz using phosphoric acid (85%) as external standard (dP 0.0). Pro-
ton chemical shifts are expressed in ppm downfield from the signal
of the methyl of Me2SO-d6 (dH/TMS 2.52 and dC/TMS 40.98). All the
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dures were described in previous studies [11, 12].
Murine Primary Macrophages
Mice deficient for TLR1 [3], for TLR6 [39], or for TLR4 and/or TLR2
obtained by intercross from TLR4-deficient mice (from S. Akira
[40]) and TLR2-deficient mice (from C. Kirsching [41]), and their con-
trol littermates were bred under specific pathogen-free conditions in
the Transgenose Institute animal breeding facility (Orleans, France).
Murine bone marrow cells were isolated from femurs and cultivated
(106/ml) for 7 days in Dulbecco’s modified Eagle medium (DMEM)
supplemented with 2 mM L-glutamine and 2 3 1025 M b-mer-
capto-ethanol, 20% horse serum, and 30% L929 cell-conditioned
medium (as source of M-CSF, as described in [42]). After resuspen-
sion in cold PBS and washing, the cells were further cultivated for 3
days in fresh medium to obtain a homogenous population of
CD11b+ macrophages.
The bone marrow-derived macrophages were plated in 96-well
microculture plates at a density of 105 cells/well in DMEM supple-
mented with L-glutamine and b-mercapto-ethanol, as above, and
stimulated with 100 ng/ml of LPS (Escherichia coli, serotype
O111:B4; Sigma), 0.5 mg/ml of synthetic bacterial lipopeptide
Pam3CSK4 ([S-[2,3-bis-(palmitoyloxy)-(2-RS)-propyl]-N-palmitoyl-
(R)-Cys-(S)-Ser-Lys4-OH], trihydrochloride; EMC Microcollections,
Tuebingen, Germany), or LM (at the concentrations indicated). The
macrophages were activated with IFN-g (500 U/ml) to study IL-12
expression. After 18–24 hr of stimulation, the supernatants were har-
vested and analyzed immediately, or stored at 220ºC until cytokine
quantification using commercially available ELISA reagents for TNF
and IL-12p40 (Duoset R&D Systems, Abingdon, UK).
THP-1 Cells
THP-1 monocyte/macrophage human cell lines were maintained as
nonadherent cells in continuous culture with RPMI 1640 medium (In-
vitrogen, Cergy Pontoise, France), 10% fetal calf serum (Life Tech-
nologies), in an atmosphere of 5% CO2 at 37ºC. LM acyl-forms
were added in triplicate to monocyte/macrophage cells (5 3 105
cells/well) in 24-well culture plates and then incubated for 20 hr at
37ºC. In order to investigate the TLR dependence of TNF-a-inducing
LM activity, anti-TLR2 (clone TL2.1; eBioscience, San Diego, CA) or
anti-TLR4 (clone HTA125; Serotec, Cergy Saint-Christophe, France)
monoclonal antibodies or an IgG2a isotype control (clone eBM2a;
eBioscience) at a concentration of 5 or 15 mg/ml were added to-
gether with LM to THP-1 cells. Supernatants from THP-1 cells
were assayed for TNF-a by sandwich ELISA using commercially
available kits and according to manufacturer’s instructions (R&D
Systems, Minneapolis, MN).
Endotoxin Measurements
Endotoxin levels in the different LM samples were quantified by LAL
kinetic turbidimetric assays (Cambrex, Verviers, Belgium).
Supplemental Data
Supplemental Data, including Table S1, are available at http://
www.chembiol.com/cgi/content/full/13/1/39/DC1/.
Acknowledgments
We gratefully acknowledge Dr. B. Monsarrat (IPBS, CNRS, Tou-
louse) for MALDI-TOF MS facilities, Dr. P. Constant and Miss B. Sichi
(IPBS, CNRS, Toulouse) for helping with THP1 experiments, and Dr.
G. Tiraby (Socie´te´ Cayla, Toulouse, France) for helpful discussions
on TLR.
Received: March 9, 2005
Revised: September 7, 2005
Accepted: October 20, 2005
Published: January 20, 2006
References
1. Flynn, J.L. (2004). Immunology of tuberculosis and implications
in vaccine development. Tuberculosis (Edinb.) 84, 93–101.2. Stenger, S., and Modlin, R.L. (2002). Control of Mycobacterium
tuberculosis through mammalian Toll-like receptors. Curr.
Opin. Immunol. 14, 452–457.
3. Takeuchi, O., Sato, S., Horiuchi, T., Hoshino, K., Takeda, K.,
Dong, Z., Modlin, R.L., and Akira, S. (2002). Cutting edge: role
of Toll-like receptor 1 in mediating immune response to micro-
bial lipoproteins. J. Immunol. 169, 10–14.
4. Krutzik, S.R., and Modlin, R.L. (2004). The role of Toll-like recep-
tors in combating mycobacteria. Semin. Immunol. 16, 35–41.
5. Gilleron, M., Quesniaux, V.F., and Puzo, G. (2003). Acylation
state of the phosphatidyl inositol hexamannosides from Myco-
bacterium bovis BCG and Mycobacterium tuberculosis H37Rv
and its implication in TLR response. J. Biol. Chem. 278,
29880–29889.
6. Vignal, C., Guerardel, Y., Kremer, L., Masson, M., Legrand, D.,
Mazurier, J., and Elass, E. (2003). Lipomannans, but not lipoara-
binomannans, purified from Mycobacterium chelonae and My-
cobacterium kansasii induce TNF-alpha and IL-8 secretion by
a CD14-Toll-like receptor 2-dependent mechanism. J. Immunol.
171, 2014–2023.
7. Quesniaux, V.J., Nicolle, D.M., Torres, D., Kremer, L., Guerardel,
Y., Nigou, J., Puzo, G., Erard, F., and Ryffel, B. (2004). Toll-like
receptor 2 (TLR2)-dependent-positive and TLR2-independent-
negative regulation of proinflammatory cytokines by mycobac-
terial lipomannans. J. Immunol. 172, 4425–4434.
8. Nigou, J., Gilleron, M., Rojas, M., Garcia, L.F., Thurnher, M., and
Puzo, G. (2002). Mycobacterial lipoarabinomannans: modula-
tors of dendritic cell function and the apoptotic response. Mi-
crobes Infect. 4, 945–953.
9. Nigou, J., Zelle-Rieser, C., Gilleron, M., Thurnher, M., and Puzo,
G. (2001). Mannosylated lipoarabinomannans inhibit IL-12 pro-
duction by human dendritic cells: evidence for a negative signal
delivered through the mannose receptor. J. Immunol. 166, 7477–
7485.
10. van Kooyk, Y., and Geijtenbeek, T.B. (2003). DC-SIGN: escape
mechanism for pathogens. Nat. Rev. Immunol. 3, 697–709.
11. Gilleron, M., Nigou, J., Cahuzac, B., and Puzo, G. (1999). Struc-
tural study of the lipomannans from Mycobacterium bovis BCG:
characterisation of multiacylated forms of the phosphatidyl-
myo-inositol anchor. J. Mol. Biol. 285, 2147–2160.
12. Gilleron, M., Ronet, C., Mempel, M., Monsarrat, B., Gachelin, G.,
and Puzo, G. (2001). Acylation state of the phosphatidylinositol
mannosides from Mycobacterium bovis bacillus Calmette Gue-
rin and ability to induce granuloma and recruit natural killer T
cells. J. Biol. Chem. 276, 34896–34904.
13. Nigou, J., Gilleron, M., and Puzo, G. (1999). Lipoarabino-
mannans: characterization of the multiacylated forms of the
phosphatidyl-myo-inositol anchor by NMR spectroscopy. Bio-
chem. J. 337, 453–460.
14. Gilleron, M., Bala, L., Brando, T., Vercellone, A., and Puzo, G.
(2000). Mycobacterium tuberculosis H37Rv parietal and cellular
lipoarabinomannans: characterization of the acyl- and glyco-
forms. J. Biol. Chem. 275, 677–684.
15. Ozinsky, A., Smith, K.D., Hume, D., and Underhill, D.M. (2000).
Co-operative induction of pro-inflammatory signaling by Toll-
like receptors. J. Endotoxin Res. 6, 393–396.
16. Bulut, Y., Faure, E., Thomas, L., Equils, O., and Arditi, M. (2001).
Cooperation of Toll-like receptor 2 and 6 for cellular activation by
soluble tuberculosis factor and Borrelia burgdorferi outer sur-
face protein A lipoprotein: role of Toll-interacting protein and
IL-1 receptor signaling molecules in Toll-like receptor 2 signal-
ing. J. Immunol. 167, 987–994.
17. Hajjar, A.M., O’Mahony, D.S., Ozinsky, A., Underhill, D.M.,
Aderem, A., Klebanoff, S.J., and Wilson, C.B. (2001). Cutting
edge: functional interactions between Toll-like receptor (TLR) 2
and TLR1 or TLR6 in response to phenol-soluble modulin. J. Im-
munol. 166, 15–19.
18. Ottenhoff, T.H., and Bevan, M.J. (2004). Host-pathogen interac-
tions. Curr. Opin. Immunol. 16, 439–442.
19. Quesniaux, V., Fremond, C., Jacobs, M., Parida, S., Nicolle, D.,
Yeremeev, V., Bihl, F., Erard, F., Botha, T., Drennan, M., et al.
(2004). Toll-like receptor pathways in the immune responses to
mycobacteria. Microbes Infect. 6, 946–959.
LM Glyco- and Acyl-Forms and Proinflammatory Response
4720. Drennan, M.B., Nicolle, D., Quesniaux, V.J., Jacobs, M., Allie, N.,
Mpagi, J., Fremond, C., Wagner, H., Kirschning, C., and Ryffel,
B. (2004). Toll-like receptor 2-deficient mice succumb to Myco-
bacterium tuberculosis infection. Am. J. Pathol. 164, 49–57.
21. Dao, D.N., Kremer, L., Guerardel, Y., Molano, A., Jacobs, W.R.,
Jr., Porcelli, S.A., and Briken, V. (2004).Mycobacterium tubercu-
losis lipomannan induces apoptosis and interleukin-12 produc-
tion in macrophages. Infect. Immun. 72, 2067–2074.
22. Beatty, W.L., Rhoades, E.R., Ullrich, H.J., Chatterjee, D., Heuser,
J.E., and Russell, D.G. (2000). Trafficking and release of myco-
bacterial lipids from infected macrophages. Traffic 1, 235–247.
23. Beatty, W.L., Ullrich, H.J., and Russell, D.G. (2001). Mycobacte-
rial surface moieties are released from infected macrophages by
a constitutive exocytic event. Eur. J. Cell Biol. 80, 31–40.
24. Schaible, U.E., Winau, F., Sieling, P.A., Fischer, K., Collins, H.L.,
Hagens, K., Modlin, R.L., Brinkmann, V., and Kaufmann, S.H.
(2003). Apoptosis facilitates antigen presentation to T lympho-
cytes through MHC-I and CD1 in tuberculosis. Nat. Med. 9,
1039–1046.
25. Schaible, U.E., Hagens, K., Fischer, K., Collins, H.L., and Kauf-
mann, S.H. (2000). Intersection of group I CD1 molecules and
mycobacteria in different intracellular compartments of den-
dritic cells. J. Immunol. 164, 4843–4852.
26. Leopold, K., and Fischer, W. (1993). Molecular analysis of the lip-
oglycans of Mycobacterium tuberculosis. Anal. Biochem. 208,
57–64.
27. Khoo, K.H., Dell, A., Morris, H.R., Brennan, P.J., and Chatterjee,
D. (1995). Structural definition of acylated phosphatidylinositol
mannosides from Mycobacterium tuberculosis: definition of
a common anchor for lipomannan and lipoarabinomannan. Gly-
cobiology 5, 117–127.
28. Guerardel, Y., Maes, E., Briken, V., Chirat, F., Leroy, Y., Locht, C.,
Strecker, G., and Kremer, L. (2003). Lipomannan and lipoarabi-
nomannan from a clinical isolate of Mycobacterium kansasii:
novel structural features and apoptosis-inducing properties. J.
Biol. Chem. 278, 36637–36651.
29. Guerardel, Y., Maes, E., Elass, E., Leroy, Y., Timmerman, P.,
Besra, G.S., Locht, C., Strecker, G., and Kremer, L. (2002). Struc-
tural study of lipomannan and lipoarabinomannan from Myco-
bacterium chelonae: presence of unusual components with al-
pha 1,3-mannopyranose side chains. J. Biol. Chem. 277,
30635–30648.
30. Akira, S. (2003). Mammalian Toll-like receptors. Curr. Opin. Im-
munol. 15, 5–11.
31. Morr, M., Takeuchi, O., Akira, S., Simon, M.M., and Muhlradt,
P.F. (2002). Differential recognition of structural details of bacte-
rial lipopeptides by toll-like receptors. Eur. J. Immunol. 32, 3337–
3347.
32. Reiling, N., Holscher, C., Fehrenbach, A., Kroger, S., Kirschning,
C.J., Goyert, S., and Ehlers, S. (2002). Cutting edge: Toll-like re-
ceptor (TLR)2- and TLR4-mediated pathogen recognition in re-
sistance to airborne infection with Mycobacterium tuberculosis.
J. Immunol. 169, 3480–3484.
33. Sugawara, I., Yamada, H., Li, C., Mizuno, S., Takeuchi, O., and
Akira, S. (2003). Mycobacterial infection in TLR2 and TLR6
knockout mice. Microbiol. Immunol. 47, 327–336.
34. Nicolle, D., Fremond, C., Pichon, X., Bouchot, A., Maillet, I.,
Ryffel, B., and Quesniaux, V.J. (2004). Long-term control of
Mycobacterium bovis BCG infection in the absence of Toll-like
receptors (TLRs): investigation of TLR2-, TLR6-, or TLR2-
TLR4-deficient mice. Infect. Immun. 72, 6994–7004.
35. Kang, T.J., Lee, S.B., and Chae, G.T. (2002). A polymorphism in
the Toll-like receptor 2 is associated with IL-12 production from
monocyte in lepromatous leprosy. Cytokine 20, 56–62.
36. Finlay, B.B., and Hancock, R.E. (2004). Can innate immunity be
enhanced to treat microbial infections? Nat. Rev. Microbiol. 2,
497–504.
37. Nigou, J., Gilleron, M., Cahuzac, B., Bounery, J.D., Herold, M.,
Thurnher, M., and Puzo, G. (1997). The phosphatidyl-myo-inosi-
tol anchor of the lipoarabinomannans from Mycobacterium bo-
vis bacillus Calmette Guerin: heterogeneity, structure, and role
in the regulation of cytokine secretion. J. Biol. Chem. 272,
23094–23103.38. Venisse, A., Berjeaud, J.M., Chaurand, P., Gilleron, M., and
Puzo, G. (1993). Structural features of lipoarabinomannan from
Mycobacterium bovis BCG: determination of molecular mass
by laser desorption mass spectrometry. J. Biol. Chem. 268,
12401–12411.
39. Takeuchi, O., Kawai, T., Muhlradt, P.F., Morr, M., Radolf, J.D.,
Zychlinsky, A., Takeda, K., and Akira, S. (2001). Discrimination
of bacterial lipoproteins by Toll-like receptor 6. Int. Immunol.
13, 933–940.
40. Hoshino, K., Takeuchi, O., Kawai, T., Sanjo, H., Ogawa, T.,
Takeda, Y., Takeda, K., and Akira, S. (1999). Cutting edge: Toll-
like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipo-
polysaccharide: evidence for TLR4 as the Lps gene product. J.
Immunol. 162, 3749–3752.
41. Michelsen, K.S., Aicher, A., Mohaupt, M., Hartung, T., Dimmeler,
S., Kirschning, C.J., and Schumann, R.R. (2001). The role of toll-
like receptors (TLRs) in bacteria-induced maturation of murine
dendritic cells (DCS): peptidoglycan and lipoteichoic acid are in-
ducers of DC maturation and require TLR2. J. Biol. Chem. 276,
25680–25686.
42. Muller, M., Eugster, H.P., Le Hir, M., Shakhov, A., Di Padova, F.,
Maurer, C., Quesniaux, V.F., and Ryffel, B. (1996). Correction or
transfer of immunodeficiency due to TNF-LT alpha deletion by
bone marrow transplantation. Mol. Med. 2, 247–255.
